HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Appearance of cytolytic granules upon induction of cytolytic activity in CTL-hybrids.

Abstract
Examining a CTL-line (B6.1) with specific cytolytic activity, we have confirmed the ability of CTL-lines to produce poly C9-like, tubular complexes of two sizes (polyperforin 1 and 2). Isolated cytoplasmic granules from this cell line can induce hemolysis and contain the lysosomal marker arylsulfatase. Electron microscopial studies show that granules contain precursor molecules which are assembled into polyperforin upon addition of Ca2+. Antibodies raised against granules predominantly react with a 27-kd protein. We compared the B6.1 cell with a hybrid, PC60, derived from a cross between B6.1 and a non-cytolytic rat-thymoma. This hybrid line exhibits inducible CTL-activity. In PC60 with induced cytolytic activity, polyperforins 1 and 2, cytolytic granules and granule-associated proteins are detected. Non-cytolytic PC60 cells lack cytolytic granules and polyperforin 1, but contain polyperforin 2. These results suggest that cytolytic granules appear in parallel with the expression of cytotoxicity during T-lymphocyte differentiation.
AuthorsD Masson, P Corthésy, M Nabholz, J Tschopp
JournalThe EMBO journal (EMBO J) Vol. 4 Issue 10 Pg. 2533-8 (Oct 1985) ISSN: 0261-4189 [Print] England
PMID2414099 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ion Channels
  • Macromolecular Substances
  • Membrane Proteins
  • Calcium
Topics
  • Animals
  • Calcium (physiology)
  • Cell Membrane (ultrastructure)
  • Cytotoxicity, Immunologic
  • Hemolysis
  • Hybrid Cells
  • Ion Channels
  • Macromolecular Substances
  • Membrane Proteins
  • Mice
  • Microscopy, Electron
  • Molecular Weight
  • T-Lymphocytes, Cytotoxic (ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: